BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BD INTIMA-II 22GAX1.00IN PRN SLM NPVC HP

    MDR report key: 23829846 · Received December 17, 2025

    Report

    Report Number
    3006948883-2025-00949
    Event Type
    Malfunction
    Date Received
    December 17, 2025
    Date of Event
    November 20, 2025
    Report Date
    February 5, 2026
    Manufacturer
    BD SUZHOU (MDS)
    Product Code
    FOZ
    PMA / PMN Number
    UNK
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CH
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    H.3. IF A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS COMPLETED, A SUPPLEMENTAL REPORT WILL BE FILED.

    Additional Manufacturer Narrative · 0

    1.THE CUSTOMER RETURNED 1 USED SAMPLE: 1)THE RETURN SAMPLE SHOWS THAT THE SEPTUM HAS MOVED. 2)CHECK THE DISTRIBUTION OF UV ADHESIVE IN THE CATHETER HUB OF THE RETURNED SAMPLE UNDER THE PURPLE LAMP. NO ABNORMALITY IS FOUND IN THE AMOUNT AND DISTRIBUTION OF UV ADHESIVE. 2. DHR/BHR REVIEW(LOT#5093665): 1)THE PRODUCTS OF THIS BATCH WERE ASSEMBLED AT INTIMA II AUTO LINE 3 IN APRIL 2025 AND PACKAGED AT CFS PACKAGE LINE IN APRIL 2025. WORK ORDER QUANTITY WAS (B)(4) PCS. 2)THE SEPTUM INCOMING INSPECTIONS: APPEARANCE AND SIZE WERE NOT ABNORMAL, WHICH MET THE REQUIREMENTS OF INCOMING INSPECTION SPECIFICATIONS. 3)THE LEAKAGE TEST RESULTS OF 160PCS IN PROCESS TESTING AND 32PCS IN OUTGOING TESTING WERE WITHIN THE PRODUCT SPECIFICATIONS. 4)NO UNQUALIFIED, DEVIATION OR REWORK ACTIVITIES IN THE PRODUCTION PROCESS. 5)THE SEPTUM ASSEMBLY EQUIPMENT WITHOUT ABNORMAL MAINTENANCE. 3. THE RETAINED SAMPLE OF THIS BATCH IS TAKEN FOR 45PSI LEAKAGE TEST. THE TESTS ARE PASSED, AND NO LEAKAGE IS FOUND AT THE SEPTUM AND OTHER PARTS OF THE SAMPLE. 4. CAUSE ANALYSIS: 1)BASED ON THE SAMPLE ANALYSIS RESULTS, THE LEAKAGE OCCURRED DUE TO DISPLACEMENT OF THE ISOLATING PLUG. THE DISPLACEMENT OF THE ISOLATING PLUG MAY BE CAUSED BY VARIOUS FACTORS: THE OUTER DIAMETER OF THE ISOLATING PLUG, THE INNER DIAMETER OF THE CATHETER SEAT, INSUFFICIENT ADHESIVE APPLIED TO THE ISOLATING PLUG, CONTAMINATION OF THE ISOLATING PLUG WITH LUBRICANT (A SOLVENT CONTAINING MEDICAL-GRADE SILICONE OIL), AND VARIATIONS IN THE RAW MATERIAL OF THE ISOLATING PLUG-ALL OF WHICH CAN AFFECT THE SEALING PERFORMANCE OF THE PRODUCT. 2)BASED ON THE RETURNED SAMPLE ANALYSIS RESULTS AND THE INFORMATION PROVIDED BY THE CUSTOMER, IT HAS BEEN CONFIRMED THAT THE OUTER DIAMETER OF THE ISOLATING PLUG, THE INNER DIAMETER OF THE CATHETER SEAT, AND THE ADHESIVE APPLIED TO THE ISOLATING PLUG ARE ALL WITHIN NORMAL PARAMETERS. THE ISSUE MAY HAVE OCCURRED DURING THE SYRINGE LUBRICATION PROCESS, WHERE THE ISOLATING PLUG WAS CONTAMINATED WITH A SMALL AMOUNT OF RESIDUAL LUBRICANT (A SOLVENT CONTAINING MEDICAL-GRADE SILICONE OIL). THIS CONTAMINATION COULD HAVE COMPROMISED THE BONDING BETWEEN THE ISOLATING PLUG AND THE CATHETER SEAT, RESULTING IN THE PRODUCT¿S INABILITY TO MAINTAIN A SEALED CONDITION UNDER SUSTAINED HIGH-PRESSURE, WHICH ULTIMATELY LED TO LEAKAGE. 5. THE PLANT HAS IMMEDIATELY IMPLEMENTED CORRESPONDING CORRECTIVE ACTIONS TO ADDRESS THE POTENTIAL CAUSES OF THIS DEFECT: 1)CLEAN THE AIR-BLOWING GROOVES AND OPTIMIZE THE POSITION OF THE ISOLATING PLUG DURING NEEDLE LUBRICATION. 2)OPTIMIZE THE SIZE OF THE LUBRICATION GROOVE TO PREVENT THE ISOLATING PLUG FROM COMING INTO DIRECT CONTACT WITH THE LUBRICANT, ENSURING PROPER BONDING BETWEEN THE ISOLATING PLUG AND THE CATHETER SEAT TO IMPROVE THE PRODUCT¿S SEALING QUALITY. THE EFFECTIVENESS OF THESE IMPROVEMENT MEASURES IS CURRENTLY BEING MONITORED. CONCLUSION(S): NO ABNORMALITIES ARE FOUND IN THE PROCESS AND RETAINED SAMPLE. BASED ON THE ANALYSIS OF THE RETURNED SAMPLES AND THE INFORMATION PROVIDED BY THE CUSTOMER, IT IS SUSPECTED THAT THE ISOLATING PLUG WAS CONTAMINATED WITH A SMALL AMOUNT OF RESIDUAL LUBRICANT, WHICH COMPROMISED THE PRODUCT¿S SEALING PERFORMANCE AND RESULTED IN ITS INABILITY TO MAINTAIN INTEGRITY UNDER HIGH-PRESSURE CONDITIONS. THIS PHENOMENON IS CONSIDERED A LOW-PROBABILITY EVENT. THE PLANT HAS CONDUCTED A COMPREHENSIVE EVALUATION OF THE RELEVANT PRODUCTION PROCESSES THAT COULD LEAD TO THIS DEFECT AND HAS IMPLEMENTED CORRECTIVE MEASURES. CONTINUOUS MONITORING OF THE DEFECT COMPLAINT TREND WILL BE CARRIED OUT.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT BD INTIMA-II 22GAX1.00IN PRN SLM NPVC HP LEAKED WITH POWER INJECTOR ON THE MORNING OF (B)(6) 2025, THE PATIENT UNDERWENT AN ABDOMINAL CONTRAST-ENHANCED CT SCAN. DURING THE HIGH-PRESSURE INJECTION OF CONTRAST AGENT VIA THE MICRO-INFUSION PUMP, A SIGNIFICANT LEAK OCCURRED AT THE UPPER SECTION OF THE WHITE ISOLATION CAP ON THE INDWELLING NEEDLE. THE NEEDLE WAS PROMPTLY REMOVED AND REINSERTED, AFTER WHICH THE CONTRAST AGENT WAS SUCCESSFULLY INJECTED, ALLOWING THE EXAMINATION TO BE COMPLETED SAFELY. THIS REINSERTION PROCEDURE CAUSED ADDITIONAL DISCOMFORT TO THE PATIENT, RESULTED IN MEDICATION WASTE, AND DELAYED THE EXAMINATION.

    Description of Event or Problem · 0

    NO ADDITIONAL INFORMATION AVAILABLE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2186459 BD INTIMA-II 22GAX1.00IN PRN SLM NPVC HP INTRAVASCULAR CATHETER FOZ BD SUZHOU (MDS) 5093665

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown